The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer
Hee Kyung Kim, Jee Hee Yoon, Jin Seong Cho, Seong Young Kwon, Su Woong Yoo, Ho-Cheol Kang
Korean J Intern Med. 2020;35(5):1164-1172. Published online 2019 Jul 29 DOI: https://doi.org/10.3904/kjim.2018.173
Citations to this article as recorded by 
Higher adjuvant radioactive iodine therapy dosage helps intermediate-risk papillary thyroid carcinoma patients achieve better therapeutic effect
Xue Li, Hongyuan Zheng, Chao Ma, Yanhui Ji, Xuan Wang, Danyang Sun, Zhaowei Meng, Wei Zheng
Frontiers in Endocrinology.2024;[Epub] CrossRef
Combined clinical variable and radiomics of post-treatment total body scan for prediction of successful I-131 ablation in low-risk papillary thyroid carcinoma patients
Maythinee Chantadisai, Jirarot Wongwijitsook, Napat Ritlumlert, Yothin Rakvongthai
Scientific Reports.2024;[Epub] CrossRef
Prognostic factors and treatment responses among patients with gross residual disease in differentiated thyroid cancer
Yvonne Ee Wern Chiew, Yi-Ting Yang, Shun-Yu Chi, Yi-Chia Chan, Yen-Hsiang Chang, Lay San Lim, Wen-Chieh Chen, Yung-Nien Chen, Shu-Ting Wu, Chen-Kai Chou
Journal of the Chinese Medical Association.2024; 87(6): 602. CrossRef
The value of serum thyroglobulin alteration after ultrasonography‐guided fine‐needle biopsy of suspicious cervical lymph nodes in the diagnosis of metastasis in patients with differentiated thyroid cancer
Fatma Dilek Dellal, Cevdet Aydin, Abbas Ali Tam, Sevgul Faki, Afra Alkan, Sefika Burcak Polat, Ahmet Dirikoc, Oya Topaloglu, Reyhan Ersoy, Bekir Cakir
International Journal of Clinical Practice.2021;[Epub] CrossRef
Ablation rate after radioactive iodine therapy in patients with differentiated thyroid cancer at intermediate or high risk of recurrence: a systematic review and a meta-analysis
Michele Klain, Carmela Nappi, Emilia Zampella, Valeria Cantoni, Roberta Green, Leandra Piscopo, Fabio Volpe, Mariarosaria Manganelli, Elisa Caiazzo, Mario Petretta, Martin Schlumberger, Alberto Cuocolo
European Journal of Nuclear Medicine and Molecular Imaging.2021; 48(13): 4437. CrossRef
Unexplained Hyperthyroglobulinemia in Differentiated Thyroid Cancer Patients as an Indication for Radioiodine Adjuvant Therapy: A Prospective Multicenter Study
Lin Cheng, Ri Sa, Qiong Luo, Hao Fu, Yuchen Jin, Linglin Tang, Yi Yang, Chunjing Yu, Libo Chen
Journal of Nuclear Medicine.2021; 62(1): 62. CrossRef
Optimization of Predictive Performance for the Therapeutic Response Using Iodine Scan-Corrected Serum Thyroglobulin in Patients with Differentiated Thyroid Carcinoma
Su Woong Yoo, Md. Sunny Anam Chowdhury, Subin Jeon, Sae-Ryung Kang, Sang-Geon Cho, Jahae Kim, Changho Lee, Young Jae Ryu, Ho-Chun Song, Hee-Seung Bom, Jung-Joon Min, Seong Young Kwon
Cancers.2020; 12(2): 262. CrossRef